Immunology and Microbiology
Allele
17%
Antibiotic Sensitivity
15%
Antimicrobial Resistance
61%
Bacteriophage
18%
Clinical Microbiology
24%
Coronavirinae
31%
Coronavirus
31%
Enterobacteriaceae
28%
Enterococcus faecium
20%
Enterovirus
44%
Escherichia coli
81%
Extended Spectrum Beta Lactamase Producing Enterobacteriaceae
17%
Genetic Variability
17%
Genotype
21%
Gram-Negative Bacteria
20%
Human Respiratory Syncytial Virus
20%
Infectious Agent
100%
Klebsiella pneumoniae
60%
Lineages
26%
Lower Respiratory Tract
15%
Metagenomics
60%
Methicillin-Resistant Staphylococcus Aureus
28%
Microbiome
26%
Microflora
16%
Microorganism
31%
Mobile Genetic Elements
20%
Multilocus Sequence Typing
54%
Murine Hepatitis Virus
21%
Next Generation Sequencing
44%
Phoca vitulina
18%
Phylogeny
40%
Pig
18%
Plasmid
64%
Polyomavirus
19%
Prevalence
45%
Real Time Polymerase Chain Reaction
35%
Real-Time Polymerase Chain Reaction
15%
Respiratory Virus
26%
Shiga Toxin
26%
Shigella
18%
Single Nucleotide Polymorphism
19%
Staphylococcus Aureus
37%
Surface Property
23%
Transmissible Gastroenteritis Virus
22%
Vancomycin-Resistant Enterococcus
25%
Verotoxin-Producing Escherichia Coli
31%
Viral Disease
16%
Viral Load
16%
Virulence Factor
23%
Whole Genome Sequencing
68%
Medicine and Dentistry
Antibiogram
9%
Antibiotic Resistance
17%
Antibiotic Therapy
6%
Antibiotics
13%
Atypical Hemolytic Uremic Syndrome
10%
Burn Unit
9%
Carbapenemase
14%
Cross Protection
9%
Cross Sectional Study
7%
Diagnosis
33%
Disease
9%
Enterobacteriaceae
15%
Enteroinvasive Escherichia Coli
9%
Enterovirus
16%
Escherichia coli
24%
Extended Spectrum Beta Lactamase
15%
Extended Spectrum Beta Lactamase Producing Enterobacteriaceae
11%
Gram-Negative Bacteria
10%
Health Care
6%
Human Papillomavirus Type 16
10%
Infection
45%
Infection Prevention
14%
Intensive Care
15%
Intensive Care Unit
10%
Klebsiella pneumoniae
21%
Lower Respiratory Tract Infection
12%
Meningitis
6%
Metallo Beta Lactamase
9%
Methicillin Resistant Staphylococcus Aureus
13%
Molecular Diagnostics
8%
Multilocus Sequence Typing
7%
Next Generation Sequencing
18%
Papillomavirus Infection
9%
Pathogen
34%
Polymerase Chain Reaction
8%
Polymerase Chain Reaction
6%
Prevalence
17%
Prospective Cohort Study
9%
Prospective Study
10%
Public Health
19%
Real Time Polymerase Chain Reaction
29%
Serotype
6%
Shiga Toxin Producing Escherichia Coli
9%
Shigella
9%
Staphylococcus Aureus
18%
Symptom
14%
Tertiary Care
9%
Thermal Burn
6%
Wart Virus
13%
Whole Genome Sequencing
11%
Keyphrases
Adenovirus
6%
Atypical Hemolytic Uremic Syndrome (aHUS)
9%
Brazil
5%
Canine Coronavirus (CCoV)
7%
Canine Enteric Coronavirus
9%
Clinical Infections
7%
Clinical Microbiology
7%
Clinical Setting
5%
Confidence Interval
7%
Core Genome multilocus Sequence Typing (cgMLST)
5%
Coronavirus
12%
Coronavirus Infections
5%
Diagnostic Value
5%
Dutch
16%
Epithelial Cells
6%
Escherichia Coli
20%
Escherichia Coli Strains
5%
Etiology
5%
Feline Enteric Coronavirus
9%
Feline Infectious Peritonitis Virus
11%
Hospitalized Patients
8%
Human Coronavirus NL63
5%
Infection Prevention
6%
Infective Endocarditis
9%
Influenza Virus
7%
KI Polyomavirus
6%
Lower Respiratory Tract Infection
9%
Methicillin-resistant Staphylococcus Aureus
7%
MHV-A59
6%
Microbiology
5%
Molecular Characterization
6%
Mouse Hepatitis Virus
5%
Netherlands
26%
Next-generation Sequencing
13%
Non-breakup
8%
Parainfluenza Virus
6%
Plasmid
5%
Polarized Epithelial Cells
5%
Public Health
6%
Quantitative PCR
10%
Respiratory Microbiome
5%
Respiratory Syncytial Virus
6%
Shigella
9%
Transmissible Gastroenteritis Virus
5%
Vancomycin-resistant Enterococci
9%
Viral
5%
Virus
10%
Virus Strains
6%
Whole Genome Sequencing
10%
WU Polyomavirus
9%
